Growth Metrics

Anaptysbio (ANAB) Accumulated Depreciation & Amortization (2016 - 2025)

Anaptysbio's Accumulated Depreciation & Amortization history spans 10 years, with the latest figure at $7.1 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization rose 1078.05% year-over-year to $7.1 million; the TTM value through Dec 2025 reached $7.1 million, up 1078.05%, while the annual FY2025 figure was $7.1 million, 1078.05% up from the prior year.
  • Accumulated Depreciation & Amortization reached $7.1 million in Q4 2025 per ANAB's latest filing, up from $428000.0 in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $7.1 million in Q4 2025 to a low of $125000.0 in Q1 2021.
  • Average Accumulated Depreciation & Amortization over 5 years is $715900.0, with a median of $378500.0 recorded in 2023.
  • Peak YoY movement for Accumulated Depreciation & Amortization: decreased 10.71% in 2021, then soared 1078.05% in 2025.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $619000.0 in 2021, then increased by 9.05% to $675000.0 in 2022, then dropped by 3.41% to $652000.0 in 2023, then decreased by 7.06% to $606000.0 in 2024, then skyrocketed by 1078.05% to $7.1 million in 2025.
  • Per Business Quant, the three most recent readings for ANAB's Accumulated Depreciation & Amortization are $7.1 million (Q4 2025), $428000.0 (Q3 2025), and $288000.0 (Q2 2025).